NASDAQ : SXTC
China SXT Pharmaceuticals, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · China
Last price 3.55 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 46.91K
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
China SXT Pharmaceuticals, Inc. (SXTC) reported revenue of 1.14M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 1.14M | 1.14M | 1.74M | 1.93M | 1.97M | 2.60M |
| Cost of Revenue | 889.35K | 889.35K | 1.37M | 1.37M | 1.55M | 1.35M |
| Gross Profit | 248.70K | 248.70K | 367.43K | 553.97K | 426.27K | 1.25M |
| Selling, General & Admin | 7.37M | 7.37M | 3.05M | 2.65M | 5.68M | 6.44M |
| Operating Expenses | 7.37M | 7.37M | 3.05M | 2.65M | 5.68M | 6.44M |
| Operating Income | -7.12M | -7.12M | -2.68M | -2.09M | -5.26M | -5.19M |
| Interest Expense | -62.97K | -62.97K | -648.71K | -553.38K | -476.78K | -36.95K |
| Interest & Investment Income | 492.00 | 9.10K | 251.00 | |||
| Other Non Operating Income (Expenses) | 980.81K | 980.81K | 25.05K | -39.04K | 149.51K | -181.58K |
| EBT Excluding Unusual Items | -6.21M | -6.21M | -3.30M | -2.68M | -5.59M | -5.41M |
| Asset Writedown | -422.92K | -349.39K | ||||
| Pretax Income | -6.21M | -6.21M | -3.30M | -3.10M | -5.93M | -5.41M |
| Income Tax Expense | 328.15K | |||||
| Net Income | -6.21M | -6.21M | -3.30M | -3.10M | -5.93M | -5.74M |
| Net Income to Common | -6.21M | -6.21M | -3.30M | -3.10M | -5.93M | -5.74M |
| Shares Outstanding (Basic) | 2.22M | 11.43M | 2.03M | |||
| Shares Outstanding (Diluted) | 2.22M | 11.43M | 2.03M | |||
| EPS (Basic) | -1.40 | -0.52 | -2.82 | |||
| EPS (Diluted) | -1.40 | -0.52 | -2.82 | |||
| Free Cash Flow | -4.02M | -4.02M | -2.35M | -1.94M | -151.44K | 205.80K |
| Free Cash Flow Per Share | -0.87 | -0.01 | 0.10 | |||
| Gross Margin | 21.85% | 21.85% | 21.11% | 28.73% | 21.62% | 48.10% |
| Operating Margin | -625.89% | -625.89% | -153.97% | -108.49% | -266.68% | -199.43% |
| Profit Margin | -545.24% | -545.24% | -189.77% | -160.67% | -301.00% | -220.43% |
| Free Cash Flow Margin | -353.01% | -353.01% | -134.83% | -100.34% | -7.68% | 7.91% |
| EBITDA | -7.05M | -7.05M | -2.60M | -1.89M | -5.01M | -4.87M |
| EBITDA Margin | -149.24% | -97.95% | -253.99% | -187.13% | ||
| D&A For EBITDA | 73.67K | 73.67K | 82.30K | 203.25K | 250.16K | 320.01K |
| EBIT | -7.12M | -7.12M | -2.68M | -2.09M | -5.26M | -5.19M |
| EBIT Margin | -153.97% | -108.49% | -266.68% | -199.43% | ||
| Revenue as Reported | 1.14M | 1.14M | 1.74M | 1.93M | 1.97M | 2.60M |
Balance sheet
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 28.18M | 28.18M | 18.10M | 12.07M | 17.37M | 15.52M |
| Short-Term Investments | 144.97K | 144.97K | 137.80K | |||
| Cash & Short-Term Investments | 28.32M | 28.32M | 18.24M | 12.07M | 17.37M | 15.52M |
| Accounts Receivable | 931.57K | 931.57K | 1.30M | 1.31M | 1.34M | 3.37M |
| Other Receivables | 2.20M | 2.20M | 474.11K | 31.63K | 230.64K | 656.77K |
| Receivables | 3.23M | 3.23M | 1.90M | 1.35M | 1.58M | 5.53M |
| Inventory | 2.96M | 2.96M | 1.13M | 809.76K | 577.56K | 1.07M |
| Restricted Cash | 368.00 | 368.00 | 30.41K | 6.84K | 45.30K | |
| Other Current Assets | 288.94K | |||||
| Total Current Assets | 34.51M | 34.51M | 21.30M | 14.23M | 19.52M | 22.45M |
| Property, Plant & Equipment | 238.52K | 238.52K | 355.21K | 564.69K | 1.27M | 1.59M |
| Other Intangible Assets | 6.33K | 6.33K | 11.81K | 19.10K | 27.87K | 38.76K |
| Other Long-Term Assets | 8.31M | 8.74M | 9.46M | |||
| Total Assets | 34.75M | 34.75M | 21.66M | 23.13M | 29.55M | 33.55M |
| Accounts Payable | 497.65K | 497.65K | 1.16M | 1.28M | 1.38M | 1.48M |
| Accrued Expenses | 1.93M | 1.93M | 1.78M | 1.59M | 1.74M | 2.01M |
| Short-Term Debt | 355.18K | 355.18K | 702.18K | 3.32M | 8.53M | 10.73M |
| Current Portion of Long-Term Debt | 8.78K | 21.33K | 7.86K | 11.40K | ||
| Current Portion of Leases | 67.98K | 67.98K | 61.23K | 58.31K | 58.09K | |
| Current Income Taxes Payable | 2.87K | 2.87K | 1.03M | 1.05M | 1.10M | 1.17M |
| Current Unearned Revenue | 104.42K | 104.42K | 58.63K | 187.66K | 165.53K | |
| Other Current Liabilities | 1.39M | 1.39M | 1.21M | 1.39M | 1.52M | 1.72M |
| Total Current Liabilities | 4.35M | 4.35M | 6.01M | 8.90M | 14.50M | 17.12M |
| Long-Term Debt | 644.39K | 644.39K | 96.26K | 117.13K | 117.86K | |
| Long-Term Leases | 53.44K | 53.44K | 115.42K | 177.54K | 247.96K | |
| Total Liabilities | 5.05M | 5.05M | 6.22M | 9.20M | 14.86M | 17.12M |
| Common Stock | 64.13M | 64.13M | 44.53M | 39.67M | 913.78K | 162.47K |
| Additional Paid-In Capital | 35.59M | 30.99M | ||||
| Retained Earnings | -34.22M | -34.22M | -28.02M | -24.71M | -21.61M | -15.69M |
| Comprehensive Income & Other | -197.88K | -197.88K | -1.08M | -1.03M | -197.57K | 956.14K |
| Shareholders' Equity | 29.71M | 29.71M | 15.44M | 13.93M | 14.69M | 16.42M |
| Total Liabilities & Equity | 34.75M | 34.75M | 21.66M | 23.13M | 29.55M | 33.55M |
| Total Debt | 1.12M | 1.12M | 983.88K | 3.70M | 8.96M | 10.74M |
| Net Cash (Debt) | 27.20M | 27.20M | 17.25M | 8.38M | 8.41M | 4.78M |
| Net Cash Per Share | 3.78 | 0.74 | 2.35 | |||
| Filing Date Shares Outstanding | 97.00 | |||||
| Total Common Shares Outstanding | 11.00 | |||||
| Working Capital | 30.16M | 30.16M | 15.28M | 5.33M | 5.02M | 5.33M |
| Book Value Per Share | 1,403,615.00 | |||||
| Tangible Book Value | 29.70M | 29.70M | 15.43M | 13.91M | 14.66M | 16.39M |
| Tangible Book Value Per Share | 1,402,541.00 | |||||
| Machinery | 1.10M | 1.10M | 1.04M | 1.19M | 1.24M | 1.27M |
| Construction In Progress | 363.08K | |||||
| Leasehold Improvements | 1.64M | 1.64M | 1.56M | 1.56M | 1.64M | 1.78M |
Cash flow statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -6.21M | -6.21M | -3.30M | -3.10M | -5.93M | -5.74M |
| Depreciation & Amortization | 143.22K | 143.22K | 151.64K | 273.07K | 250.16K | 320.01K |
| Other Amortization | 520.79K | 292.77K | 335.65K | 29.93K | ||
| Loss (Gain) From Sale of Assets | 10.47K | |||||
| Asset Writedown & Restructuring Costs | 422.92K | 349.39K | ||||
| Stock-Based Compensation | 5.31M | 5.31M | 352.10K | 554.57K | 2.33M | |
| Provision & Write-off of Bad Debts | 128.26K | 128.26K | 263.97K | 283.23K | 2.88M | 477.30K |
| Other Operating Activities | -999.41K | -999.41K | 983.19K | -72.06K | 73.03K | 939.70K |
| Change in Accounts Receivable | 291.13K | 291.13K | -257.08K | -321.42K | 912.95K | 831.47K |
| Change in Inventory | -509.59K | -509.59K | -302.35K | -190.29K | 409.09K | 300.12K |
| Change in Accounts Payable | -693.48K | -693.48K | -114.08K | -29.25K | 9.70K | -22.79K |
| Change in Income Taxes | 15.82K | 15.82K | -15.84K | 1.56K | 27.05K | -32.00K |
| Change in Other Net Operating Assets | -1.49M | -1.49M | -282.37K | 157.84K | 56.72K | 826.26K |
| Operating Cash Flow | -4.02M | -4.02M | -2.35M | -1.93M | -80.76K | 268.29K |
| Capital Expenditures | -2.02K | -7.06K | -70.68K | -62.49K | ||
| Sale of Property, Plant & Equipment | 65.54K | |||||
| Sale (Purchase) of Intangibles | -1.25M | -1.25M | ||||
| Other Investing Activities | 33.49K | 58.38K | 15.58K | |||
| Investing Cash Flow | -1.25M | -1.25M | 63.52K | 26.42K | -12.30K | -46.91K |
| Short-Term Debt Issued | 7.43M | 1.06M | 3.72M | 2.80M | ||
| Long-Term Debt Issued | 520.72K | 520.72K | 258.00K | 433.93K | 309.42K | |
| Total Debt Issued | 520.72K | 520.72K | 7.69M | 1.50M | 4.03M | 2.80M |
| Short-Term Debt Repaid | -3.93M | -2.83M | -3.81M | |||
| Long-Term Debt Repaid | -376.56K | -376.56K | -1.92M | -78.65K | -26.11K | -33.05K |
| Total Debt Repaid | -376.56K | -376.56K | -1.92M | -4.01M | -2.85M | -3.85M |
| Net Debt Issued (Repaid) | 144.16K | 144.16K | 5.77M | -2.51M | 1.18M | -1.04M |
| Issuance of Common Stock | 14.29M | 14.29M | 2.76M | 2.19M | 3.12M | |
| Other Financing Activities | -135.00K | -110.36K | -431.74K | -478.29K | ||
| Financing Cash Flow | 14.43M | 14.43M | 8.40M | -2.62M | 2.94M | 1.60M |
| Foreign Exchange Rate Adjustments | 881.66K | 881.66K | -65.09K | -765.23K | -1.05M | 394.12K |
| Net Cash Flow | 10.05M | 10.05M | 6.05M | -5.29M | 1.80M | 2.21M |
| Free Cash Flow | -4.02M | -4.02M | -2.35M | -1.94M | -151.44K | 205.80K |
| Free Cash Flow Margin | -353.01% | -353.01% | -134.83% | -100.34% | -7.68% | 7.91% |
| Free Cash Flow Per Share | -0.87 | -0.01 | 0.10 | |||
| Levered Free Cash Flow | -4.74M | -4.74M | -2.57M | -1.15M | 1.78M | 2.31M |
| Unlevered Free Cash Flow | -4.70M | -4.70M | -2.68M | -1.10M | 1.75M | 2.31M |
| Cash Interest Paid | 21.45K | 21.45K | 21.24K | 24.53K | 13.05K | 3.20K |
| Cash Income Tax Paid | 16.73K | |||||
| Change in Working Capital | -2.39M | -2.39M | -971.74K | -381.56K | 1.42M | 1.90M |
Ratios
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 42.95K | 1.42M | 32.93M | |||
| Enterprise Value | -27.16M | -18.68M | 24.29M | |||
| Last Close Price | 3.25 | 13,440.00 | 2,994,000.00 | 16,122,841.00 | 67,523,810.00 | 1,400,000,000.00 |
| PS Ratio | 0.04 | 1.25 | 18.92 | |||
| PB Ratio | 0.00 | 0.05 | 2.13 | |||
| P/TBV Ratio | 0.00 | 0.05 | 2.13 | |||
| EV/Sales Ratio | 13.96 | |||||
| Debt / Equity Ratio | 0.04 | 0.04 | 0.06 | 0.27 | 0.61 | 0.65 |
| Debt / FCF Ratio | 52.20 | |||||
| Net Debt / Equity Ratio | -0.92 | -0.92 | -1.12 | -0.60 | -0.57 | -0.29 |
| Net Debt / EBITDA Ratio | 3.86 | 3.86 | 6.64 | 4.43 | 1.68 | 0.98 |
| Net Debt / FCF Ratio | 6.77 | 6.77 | 7.35 | 4.33 | 55.52 | -23.24 |
| Asset Turnover | 0.04 | 0.04 | 0.08 | 0.07 | 0.06 | 0.08 |
| Inventory Turnover | 0.43 | 0.43 | 1.42 | 1.98 | 1.88 | 1.10 |
| Quick Ratio | 7.23 | 7.23 | 3.33 | 1.51 | 1.31 | 1.14 |
| Current Ratio | 7.93 | 7.93 | 3.54 | 1.60 | 1.35 | 1.31 |
| Return on Equity (ROE) | -27.49% | -27.49% | -22.50% | -21.65% | -38.15% | -35.42% |
| Return on Assets (ROA) | -15.78% | -15.78% | -7.48% | -4.96% | -10.42% | -9.53% |
| Return on Invested Capital (ROIC) | -284.06% | -284.06% | -35.35% | -58.67% | -39.22% | |
| Return on Capital Employed (ROCE) | -23.40% | -23.40% | -17.10% | -14.70% | -34.90% | -31.60% |
| Earnings Yield | -14,448.57% | -435.56% | -10.03% | |||
| FCF Yield | -9,354.67% | -282.00% | -7.13% | |||
| Buyback Yield / Dilution | 80.60% | -462.87% | 86.91% |